At the molecular level, vitamin C exerts a synergistic anti-AML effect by downregulating the serine synthesis enzyme PHGDH as well as the anti-apoptotic gene BCL-2 (Long et al., 2022). This evidence concerns the gene BCL2 and acute myeloid leukemia.